Leerink Swann Starts IMS Health Holdings (IMS) at Outperform

Go back to Leerink Swann Starts IMS Health Holdings (IMS) at Outperform

Wells Fargo Starts IMS Health Holdings (IMS) at Outperform

May 14, 2014 9:22 AM EDT

Wells Fargo initiated coverage on IMS Health Holdings (NYSE: IMS) with an Outperform rating and a price target of $26-$29.

Analyst Jamie Stockton said, "We are initiating coverage of IMS Health Holdings, Inc. with an Outperform rating and a 12-month valuation range of... More

William Blair Starts IMS Health Holdings (IMS) at Outperform

May 14, 2014 7:25 AM EDT

William Blair initiated coverage on IMS Health Holdings (NYSE: IMS) with an Outperform rating.

For an analyst ratings summary and ratings history on IMS Health Holdings click here. For more ratings news on IMS Health Holdings click here.

Shares of IMS Health Holdings closed at $25.21 yesterday.

... More

SunTrust Starts IMS Health Holdings (IMS) at Neutral

May 14, 2014 7:25 AM EDT

SunTrust Robinson Humphrey initiated coverage on IMS Health Holdings (NYSE: IMS) with a Neutral rating and a price target of $25.00.

For an analyst ratings summary and ratings history on IMS Health Holdings... More

Morgan Stanley Starts IMS Health Holdings (IMS) at Equalweight

May 14, 2014 7:24 AM EDT

Morgan Stanley initiated coverage on IMS Health Holdings (NYSE: IMS) with an Equalweight rating and a price target of $26.00.

For an analyst ratings summary and ratings history on IMS Health Holdings... More

Mizuho Securities Starts IMS Health Holdings (IMS) at Buy

May 14, 2014 7:23 AM EDT

Mizuho Securities initiates coverage on IMS Health Holdings (NYSE: IMS) with a Buy rating and a price target of $29.00.

For an analyst ratings summary and ratings history on IMS Health Holdings... More

Barclays Starts IMS Health Holdings (IMS) at Equalweight

May 14, 2014 7:22 AM EDT

Barclays initiated coverage on IMS Health Holdings (NYSE: IMS) with an Equalweight rating and a price target of $27.00.

For an analyst ratings summary and ratings history on IMS Health Holdings click here. For more ratings news on IMS Health Holdings click here.

Shares of IMS Health Holdings closed at $25.21 yesterday.

... More

Stifel Nicolaus Starts IMS Health Holdings (IMS) at Buy

May 14, 2014 7:21 AM EDT

Stifel Nicolaus initiated coverage on IMS Health Holdings (NYSE: IMS) with a Buy rating and a price target of $29.00.

For an analyst ratings summary and ratings history on IMS Health Holdings... More

JPMorgan Starts IMS Health Holdings (IMS) at Overweight

May 14, 2014 7:21 AM EDT

JPMorgan initiated coverage on IMS Health Holdings (NYSE: IMS) with an Overweight rating and a price target of $28.00.

For an analyst ratings summary and ratings history on IMS Health Holdings click here. For more ratings news on IMS Health Holdings click here.

Shares of IMS Health Holdings closed at $25.21 yesterday.

... More

Deutsche Bank Starts IMS Health Holdings (IMS) at Buy

May 14, 2014 7:20 AM EDT

Deutsche Bank initiated coverage on IMS Health Holdings (NYSE: IMS) with a Buy rating and a price target of $28.00.

Analyst Paul Ginocchio said, "IMS Health is in the early stages of the move from a $5bn up to a $75bn addressable... More

Goldman Sachs Starts IMS Health Holdings (IMS) at Neutral

May 14, 2014 7:19 AM EDT

Goldman Sachs initiated coverage on IMS Health Holdings (NYSE: IMS) with a Neutral rating and a price target of $25.00.

Analyst Andre Benjamin said, "We initiate coverage of IMS with a Neutral rating due to a valuation that, in our view, fairly reflects IMS strong... More

Piper Jaffray Starts IMS Health Holdings (IMS) at Overweight

May 14, 2014 7:12 AM EDT

Piper Jaffray initiates coverage on recent IPO IMS Health Holdings (NYSE: IMS) with a Overweight rating and a price target of $28.00.

Analyst Peter Appert comments, "We are initiating coverage of IMS Health with an Overweight rating following the companys... More

BofA/Merrill Lynch Starts IMS Health Holdings (IMS) at Buy

May 14, 2014 6:14 AM EDT

BofA/Merrill Lynch initiates coverage on IMS Health Holdings (NYSE: IMS) with a Buy rating and a price target of $28.00.

Analyst Robert Willoughby notes a 99% customer retention rate. Also new management positioned the company for more rapid growth in larger markets with the... More